Mutations in the SASPase gene (ASPRV1) are not associated with atopic eczema or clinically dry skin

Journal of Investigative Dermatology

Volumn 132, Issue 5, 2012, Pages 1507-1510

  Sandilands, Aileen ^a   Brown, Sara J ^a,b   Goh, Christabelle S ^a   Pohler, Elizabeth ^a   Wilson, Neil J ^a   Campbell, Linda E ^a   Miyamoto, Kenichi ^c   Kubo, Akiharu ^c   Irvine, Alan D ^d,e   Thawer Esmail, Fatema ^f   Munro, Colin S ^g   McLean, W H Irwin ^a   Kudoh, Jun ^c   Amagai, Masayuki ^c   Matsui, Takeshi ^h  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^h KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; FILAGGRIN; MONOMER; SKIN SPECIFIC RETROVIRAL LIKE ASPARTIC PROTEASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRY SKIN; ECZEMA; ENZYME ACTIVITY; EPIDERMIS; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; INFANT; IRELAND; LETTER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN; SOUTH AFRICA; TISSUE SPECIFICITY; UNITED KINGDOM;

EID: 84859745012     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.479     Document Type: Letter

References (12)

1. Bernard D, Mehul B, Thomas-Collignon A et al. (2005) Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis. J Invest Dermatol 125:278-87 (Pubitemid 41648161)
2. Bonnart C, Deraison C, Lacroix M et al. (2010) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120:871-82
3. Emerson RM, Charman CR, Williams HC (2000) The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 142: 288-97 (Pubitemid 30117700)
4. Hewett DR, Simons AL, Mangan NE et al. (2005) Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14:335-46
5. Kezic S, O'Regan GM, Yau N et al. (2011) Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 66:934-40
6. Leyvraz C, Charles RP, Rubera I et al. (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170:487-96 (Pubitemid 41126947)
7. List K, Szabo R, Wertz PW et al. (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163:901-10 (Pubitemid 37517896)
8. Matsui T, Miyamoto K, Kubo A et al. (2011) SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing. EMBO Mol Med 3:320-33
9. O'Regan GM, Irvine AD (2010) The role of filaggrin in the atopic diathesis. Clin Exp Allergy 40:965-72
10. Sandilands A, Terron-Kwiatkowski A, Hull PR et al. (2007) Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39: 650-4 (Pubitemid 46676107)
11. Sergeant A, Campbell LE, Hull PR et al. (2009) Heterozygous null alleles in filaggrin contribute to clinical dry skin in young adults and the elderly. J Invest Dermatol 129:1042-5
12. Williams HC, Burney PG, Pembroke AC et al. (1994) The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 131: 406-16 (Pubitemid 24290228)